• myGriffith
    • Staff portal
    • Contact Us⌄
      • Future student enquiries 1800 677 728
      • Current student enquiries 1800 154 055
      • International enquiries +61 7 3735 6425
      • General enquiries 07 3735 7111
      • Online enquiries
      • Staff phonebook
    View Item 
    •   Home
    • Griffith Research Online
    • Journal articles
    • View Item
    • Home
    • Griffith Research Online
    • Journal articles
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

  • All of Griffith Research Online
    • Communities & Collections
    • Authors
    • By Issue Date
    • Titles
  • This Collection
    • Authors
    • By Issue Date
    • Titles
  • Statistics

  • Most Popular Items
  • Statistics by Country
  • Most Popular Authors
  • Support

  • Contact us
  • FAQs
  • Admin login

  • Login
  • Secondary prevention of coronary heart disease: Risk factors must be assessed and treatment targets met to prevent patients with coronary heart disease having a further cardiovascular event

    Thumbnail
    View/Open
    62815_1.pdf (303.5Kb)
    Author(s)
    Hamilton-Craig, Ian
    Griffith University Author(s)
    Hamilton-Craig, Ian
    Year published
    2009
    Metadata
    Show full item record
    Abstract
    Patients with coronary heart disease (CHD) have a more than 20% risk of having a further cardiovascular disease event within five years. 堐atients with CHD should be screened for dyslipidaemia at six to eight weeks after an MI and for diabetes at least eight weeks after an MI. 堄uplex ultrasound can be used to check for carotid, abdominal aortic and femoropopliteal atherosclerosis in patients with CHD. 堉t is standard to give the SAAB regimen (a statin, aspirin, an angiotensin-converting enzyme inhibitor and a beta blocker) to patients who have had an acute coronary syndrome. 堂lood pressure targets in patients with CHD are ...
    View more >
    Patients with coronary heart disease (CHD) have a more than 20% risk of having a further cardiovascular disease event within five years. 堐atients with CHD should be screened for dyslipidaemia at six to eight weeks after an MI and for diabetes at least eight weeks after an MI. 堄uplex ultrasound can be used to check for carotid, abdominal aortic and femoropopliteal atherosclerosis in patients with CHD. 堉t is standard to give the SAAB regimen (a statin, aspirin, an angiotensin-converting enzyme inhibitor and a beta blocker) to patients who have had an acute coronary syndrome. 堂lood pressure targets in patients with CHD are determined by the presence of diabetes, renal dysfunction and proteinuria. 堁ssessment and treatment of depression and social isolation are important in the overall management of patients with CHD.
    View less >
    Journal Title
    Medicine Today
    Volume
    10
    Issue
    1
    Publisher URI
    http://www.medicinetoday.com.au/
    Copyright Statement
    © 2009 Medicine Today. The attached file is reproduced here in accordance with the copyright policy of the publisher. Please refer to the journal's website for access to the definitive, published version.
    Subject
    Cardiorespiratory Medicine and Haematology not elsewhere classified
    Medical and Health Sciences
    Publication URI
    http://hdl.handle.net/10072/30237
    Collection
    • Journal articles

    Footer

    Disclaimer

    • Privacy policy
    • Copyright matters
    • CRICOS Provider - 00233E

    Tagline

    • Gold Coast
    • Logan
    • Brisbane - Queensland, Australia
    First Peoples of Australia
    • Aboriginal
    • Torres Strait Islander